# In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma

> clinical trial · VERIFIED · 2026-07-20

Status: RECRUITING · Sponsor: Chongqing Precision Biotech Co., Ltd · Condition: Relapsed or Refractory Multiple Myeloma (RRMM)

- Company: Chongqing Precision Biotech Co., Ltd
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07715630

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.